Articles, Talks, and Insights
AbbVie strikes $1.2B deal for Gilgamesh’s psychedelic depression therapy
AbbVie strikes $1.2B deal for Gilgamesh’s psychedelic depression therapy
AbbVie strikes $1.2B deal for Gilgamesh’s psychedelic depression therapy
September 24, 2025
September 24, 2025
September 24, 2025
Bio+Health GP Dave Messina on Quantum Computing for Health at Europe's Largest Deep Tech Conference
Bio+Health GP Dave Messina on Quantum Computing for Health at Europe's Largest Deep Tech Conference
Bio+Health GP Dave Messina on Quantum Computing for Health at Europe's Largest Deep Tech Conference
April 11, 2025
April 11, 2025
April 11, 2025
Bio+Health GP Dave Messina's podcast on why now is the best time to start a health company
Bio+Health GP Dave Messina's podcast on why now is the best time to start a health company
Bio+Health GP Dave Messina's podcast on why now is the best time to start a health company
April 11, 2025
April 11, 2025
April 11, 2025